WOUND CARE FORMULATION

Paul McCarron (Inventor), Mark Jenkins (Inventor), Ryan Loughlin (Inventor)

Research output: Patent

Abstract

A gel formulation for use in filling a wound cavity and delivering active ingredient thereto, having a pH range of 6.5 to 7.5, low bioadhesive strength and cohesive integrity and being a PVA borate gel including an active ingredient and a modulator to bind borate and/or PVA in aqueous solution through a mono-diol or di-diol formation and reduces the pH of PVA-borate hydrogels. A suitable modulator is a sugar alcohol such as mannitol and the active ingredient, a medicament suitable for topical application such as a local anaesthetic and/or an antibiotic.
LanguageEnglish
Patent number12/733,776
Priority date1/03/16
Publication statusPublished - 1 Mar 2016

Fingerprint

Borates
Modulators
Gels
Sugar Alcohols
Hydrogels
Mannitol
Local Anesthetics
Anti-Bacterial Agents

Keywords

  • n/a

Cite this

McCarron, P., Jenkins, M., & Loughlin, R. (2016). WOUND CARE FORMULATION. (Patent No. 12/733,776).
McCarron, Paul (Inventor) ; Jenkins, Mark (Inventor) ; Loughlin, Ryan (Inventor). / WOUND CARE FORMULATION. Patent No.: 12/733,776.
@misc{60703b75d5674eed8baec0199cbed5f7,
title = "WOUND CARE FORMULATION",
abstract = "A gel formulation for use in filling a wound cavity and delivering active ingredient thereto, having a pH range of 6.5 to 7.5, low bioadhesive strength and cohesive integrity and being a PVA borate gel including an active ingredient and a modulator to bind borate and/or PVA in aqueous solution through a mono-diol or di-diol formation and reduces the pH of PVA-borate hydrogels. A suitable modulator is a sugar alcohol such as mannitol and the active ingredient, a medicament suitable for topical application such as a local anaesthetic and/or an antibiotic.",
keywords = "n/a",
author = "Paul McCarron and Mark Jenkins and Ryan Loughlin",
note = "Country: United States Patent Application Date: 2008-09-16; 12/733,776",
year = "2016",
month = "3",
day = "1",
language = "English",
type = "Patent",

}

McCarron, P, Jenkins, M & Loughlin, R 2016, WOUND CARE FORMULATION, Patent No. 12/733,776.

WOUND CARE FORMULATION. / McCarron, Paul (Inventor); Jenkins, Mark (Inventor); Loughlin, Ryan (Inventor).

Patent No.: 12/733,776.

Research output: Patent

TY - PAT

T1 - WOUND CARE FORMULATION

AU - McCarron, Paul

AU - Jenkins, Mark

AU - Loughlin, Ryan

N1 - Country: United States Patent Application Date: 2008-09-16

PY - 2016/3/1

Y1 - 2016/3/1

N2 - A gel formulation for use in filling a wound cavity and delivering active ingredient thereto, having a pH range of 6.5 to 7.5, low bioadhesive strength and cohesive integrity and being a PVA borate gel including an active ingredient and a modulator to bind borate and/or PVA in aqueous solution through a mono-diol or di-diol formation and reduces the pH of PVA-borate hydrogels. A suitable modulator is a sugar alcohol such as mannitol and the active ingredient, a medicament suitable for topical application such as a local anaesthetic and/or an antibiotic.

AB - A gel formulation for use in filling a wound cavity and delivering active ingredient thereto, having a pH range of 6.5 to 7.5, low bioadhesive strength and cohesive integrity and being a PVA borate gel including an active ingredient and a modulator to bind borate and/or PVA in aqueous solution through a mono-diol or di-diol formation and reduces the pH of PVA-borate hydrogels. A suitable modulator is a sugar alcohol such as mannitol and the active ingredient, a medicament suitable for topical application such as a local anaesthetic and/or an antibiotic.

KW - n/a

M3 - Patent

M1 - 12/733,776

ER -

McCarron P, Jenkins M, Loughlin R, inventors. WOUND CARE FORMULATION. 12/733,776. 2016 Mar 1.